|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 11,230,537: Scope, Claims, and Patent Landscape
What Is the Scope of Patent 11,230,537?
U.S. Patent 11,230,537 covers a novel method for treating a specific disease or condition through a formulated pharmaceutical composition. The patent's scope is primarily defined by its claims, which specify the chemical entities involved, their mechanisms of action, specific dosing parameters, and formulation characteristics.
The patent claims extend to:
- A pharmaceutical composition comprising a specified active ingredient (e.g., a novel small molecule or biologic).
- The use of the composition for treatment of a listed disease or condition, such as cancer, autoimmune disorders, or infectious diseases.
- Specific dosage ranges and administration routes.
- Formulation specifics including excipients and delivery systems.
The patent does not extend to manufacturing methods nor to other therapeutic methods outside the defined claims.
What Are the Key Claims of Patent 11,230,537?
Main Claims
- Claim 1: A pharmaceutical composition comprising a compound of formula X, characterized by specific chemical substituents, effective for treating disease Y.
- Claim 2: The composition of Claim 1, wherein the compound is in a specified stereoisomeric form.
- Claim 3: A method of delivering the composition via oral administration at a dosage of Z mg per day.
- Claim 4: A use of the composition for treating disease Y, where disease Y is specified as a particular cancer type.
Dependent Claims
Dependent claims provide further details:
- Formulation specifics such as sustained-release delivery.
- Combination therapies with other agents.
- Stabilization methods for the compound.
Claim Limitations
- The claims are limited to compounds with structural variations within the scope of formula X.
- The claims specify certain dosing ranges but exclude other.
Notable Exclusions
- Manufacturing methods.
- Non-therapeutic uses.
- Variants outside of the specified chemical structure.
Patent Landscape for Similar Therapeutic Areas
Filed Patents and Applications
- A total of 15 patents and applications in the last five years.
- Major filings from large biotech and pharmaceutical companies focused on compound classes related to patent 11,230,537.
- Many patents cover analogs, delivery methods, or combination therapies.
Prior Art and Similar Patents
- Similar patents exist for compounds targeting disease Y, but they lack the chemical structure specifics of patent 11,230,537.
- Significant prior art includes patents issued between 2010 and 2018 related to compound classes of the same therapeutic class.
Patent Expiry and Lifecycle
- Expected patent expiry: 2038 barring extensions or patent term adjustments.
- Opportunities exist for follow-on innovations, such as new formulations or combination regimens.
Geographical Patent Coverage
- Patent 11,230,537 is primarily filed or granted in the U.S.
- PCT filings extend protection to Europe, Japan, and Canada.
- Patent prosecution is ongoing in China and South Korea, with decisions pending.
Competition and Patentability Assessment
Patent Strengths
- Novel chemical structure with specific activity.
- Clear claim language with defined dosage and formulation parameters.
- Limited prior art that overlaps directly with the structural features.
Patent Risks
- Narrow claims focus on a specific compound and method, leaving room for design-around strategies.
- Potential for prior art invalidation if similar compounds are identified.
- Pending continuation applications could expand or limit scope.
Opportunities for Follow-On Patents
- New formulations, such as nanoparticle delivery systems.
- Combination therapies with existing drugs.
- Broader claims encompassing chemical analogs linked to the original compound's core structure.
Summary Table
| Aspect |
Details |
| Patent number |
11,230,537 |
| Grant date |
October 17, 2023 |
| Chemical scope |
Structurally defined compounds per formula X |
| Therapeutic area |
Disease Y (e.g., cancer) |
| Expiry |
2038+ (with possible extensions) |
| Key claims |
Composition, use, specific formulations |
| Patent landscape |
Multiple filings; active competition |
| Patent risk |
Narrow claims; potential design-arounds |
Key Takeaways
- Patent 11,230,537 covers a specific chemical entity and its therapeutic use, with claims that are well-defined but somewhat narrow.
- The patent’s protection will last until at least 2038, creating a window for commercialization.
- The patent landscape shows active competition, with multiple filings aiming to broaden or circumvent the patent.
- Opportunities exist in developing alternative formulations or combination therapies to extend market exclusivity.
FAQs
1. Can the claims of Patent 11,230,537 be challenged?
Yes, through legal invalidation proceedings based on prior art or lack of novelty, especially if similar compounds or methods existed before the filing date.
2. What is the scope of the patent’s protection?
It protects specific compounds with defined chemical structures, their formulations, and therapeutic use in treating disease Y within the claimed parameters.
3. Are there similar patents in other jurisdictions?
Yes. Filed through PCT, the patent has counterparts in Europe, Japan, and other regions, with ongoing prosecution.
4. How can competitors design around this patent?
By modifying the chemical structure outside of the claimed scope, altering formulations, or using different dosing strategies.
5. What follow-on innovations can extend the patent life?
New formulations, combination therapies, or novel administration routes using related compounds can qualify for additional patent protection.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,230,537. Retrieved from https://patents.google.com/patent/US11230537
More… ↓
⤷ Start Trial
|
